The IPV Therapy Clinical Evidence Brochure offers an overview of key clinical studies that highlight the efficacy and safety of intrapulmonary percussive ventilation (IPV) therapy across diverse patient populations.

The IPV Therapy Clinical Evidence Brochure offers an overview of key clinical studies that highlight the efficacy and safety of intrapulmonary percussive ventilation (IPV) therapy across diverse patient populations. This brochure provides healthcare professionals with an understanding of the clinical utility and benefits of IPV therapy as demonstrated in the available evidence.

By overcoming the limitations of end-tidal CO2 and providing better compatibility with all modes of ventilation, transcutaneous CO2 monitoring helps clinicians assess patient condition and the efficacy of treatment and ventilatory support strategies.

Transcutaneous CO2 monitoring (tcPCO2) is considered by many neonatal teams to be standard of care in the NICU for intubated patients – but many children’s hospitals utilize this technology across many more patient types and care settings. This document explores tcPCO2 in clinical settings, demonstrating the impact that this technology can have throughout a children’s hospital.

With a full suite of devices, IPV therapy is designed to support a wide range of patients facing these respiratory challenges — providing seamless care from hospital to home.

IPV therapy is a safe and well-tolerated airway clearance therapy that can be used with a diverse set of patient populations, care settings, and delivery interfaces.

The Sentec suite of attachment options for transcutaneous CO2 monitoring allows care teams to confidently choose solutions that support the clinical priorities of each patient — across populations and care settings.

Learn more about how a level IV NICU team was recently successful in developing an all-encompassing strategy to drive consistent utilization of transcutaneous monitoring with the goal of improving patient care.

In NICUs, PICUs, and sleep labs around the world, transcutaneous monitoring has increasingly become a trusted tool for continuous, noninvasive CO2 measurement. The technology can help reduce the need for frequent blood draws, enable proactive ventilator management, and offer additional benefits as care teams support diverse patient populations.

Diagnosed with spinal muscular atrophy shortly after birth, Stella relies on intrapulmonary percussive ventilation (IPV) therapy as a key part of her daily routine. By offering a proactive approach to her at-home respiratory care, IPV therapy empowers Stella and her family to embrace an active and fulfilling lifestyle with confidence.